期刊文献+

泮托拉唑治疗非曲张静脉上消化道出血的临床效果观察 被引量:2

Observation on Clinical Effect of Pantoprazole in the Treatment of Non-Varicose Upper Gastrointestinal Bleeding
下载PDF
导出
摘要 目的探讨泮托拉唑治疗非曲张静脉上消化道出血的临床效果。方法选取我院2016年1月至2018年12月收治的66例非曲张静脉上消化道出血患者,随机分为观察组和对照组各33例。两组均给予常规治疗,在此基础上对照组给予奥美拉唑钠治疗,观察组给予泮托拉唑治疗。观察两组的治疗效果及安全性。结果观察组的总有效率为96.97%,显著高于对照组的78.79%(P <0.05)。观察组的出血总量明显低于对照组,出血停止时间及住院时间明显短于对照组(P均<0.05)。观察组治疗期间的不良反应发生率为6.06%,与对照组的9.09%比较差异无统计学意义(P>0.05)。结论泮托拉唑治疗非曲张静脉上消化道出血,可显著改善患者的临床症状,且安全性高,值得推广。 Objective To explore the clinical effect of pantoprazole in the treatment of non-varicose upper gastrointestinal bleeding.Methods 66 cases of patients with non-varicose upper gastrointestinal bleeding admitted to our hospital from January 2016 to December2018 were selected and randomly divided into observation group and control group, with 33 cases in each group. Both groups were given routine treatment. On this basis, the control group was treated with omeprazole sodium, while the observation group was treated with pantoprazole. Results The total effective rate of the observation group was 96.97%, significantly higher than 78.79% of the control group(P<0.05). The total blood loss of the observation group was significantly lower than that of the control group, and the bleeding cessation time and hospitalization time were significantly shorter than those of the control group, with statistical differences(P <0.05). The incidence of adverse reactions during treatment of the observation group was 6.06%, had no statistical difference with 9.09% of the control group(P>0.05). Conclusions Pantoprazole in the treatment of non-variceal upper gastrointestinal bleeding can significantly improve the clinical symptoms of patients with high safety, which is worthy of promotion.
作者 林月雄 戴思平 刘子永 王辉 LIN Yuexiong;DAI Siping;LIU Ziyong;WANG Hui(Department of Emergency, Huizhou Third People's Hospital, Huizhou 516001, China)
出处 《临床医学工程》 2019年第7期955-956,共2页 Clinical Medicine & Engineering
关键词 泮托拉唑 非曲张静脉上消化道出血 临床效果 Pantoprazole Non-varicose upper gastrointestinal bleeding Clinical effect
  • 相关文献

二级参考文献86

  • 1黄莹太.对联合应用泮托拉唑和奥曲肽治疗非静脉曲张性上消化道出血的有效性及安全性探讨[J].当代医药论丛,2014,12(13):294-295. 被引量:6
  • 2廖云彪,罗锡彬,赖伟文.泮托拉唑预防重症脑出血并发应激性溃疡出血[J].实用全科医学,2004,2(6):530-531. 被引量:3
  • 3卓安山,陈爱娟,宫锋,周建光.泮托拉唑防治急危重症患者消化道出血的疗效观察[J].中国急救医学,2006,26(8):629-630. 被引量:7
  • 4卓安山,陈爱娟,宫锋,周建光.泮托拉唑对急危重症患者消化道出血的防治作用[J].上海医学,2007,30(2):128-129. 被引量:6
  • 5Canadian Cardiovascular Society, American Academy of Family Physicians, American College of Cardiology, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the manangement of patients with ST-elevation myocardil infrction: a report of the American college of Cardiology/American Heart Association Task Force on Practice Guidelines [ J ].J Am Coil Cardiol,2008,51 (2) : 210 -247.
  • 6Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine [ J ]. J Am Coil Cardiol, 2007,50 (7) :e1-e157.
  • 7Vaehhani R, Bouhaidar D,Zfass A,et al. Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduetion [ J]. Ther Clin Risk Manag,2010,6:287-292.
  • 8Devi DP,Susham M, Guido S. Drug-indueed upper gastrointestinal disorders requiring hospitalization: a five-year study in a South Indian hospital [ J ]. Pharmaeoepidemiol Drug Saf, 2004,13 ( 12 ) : 859 -862.
  • 9Kaufman DW, Kelly JP, Wiholm BE, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption [ J ]. Am J Gastroenterol, 1999,94( 11 ) :3189-3196.
  • 10Verhamme K, Mosis G, Dieleman J, et al. Spironolactone and risk of upper gastrointestinal events: population based case-control study [ J].BMJ,2006,333 (7563) :330.

共引文献252

同被引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部